Vanishing act: A case report of atovaquone–proguanil‐induced vanishing bile duct syndrome in a pediatric patient

Drug-induced vanishing bile duct syndrome (VBDS) is a rare complication of severe cholestatic hepatitis characterized by progressive ductopenia despite withdrawal of the offending agent. Prognosis ranges from gradual recovery to liver failure requiring transplantation. We report the first known pediatric case of biopsy-confirmed VBDS following atovaquone-proguanil exposure. An 11-year-old girl developed severe cholestatic hepatitis approximately 2 months after a 21-day course of malaria prophylaxis. Liver biopsy demonstrated marked ductopenia, with bile ducts identified in only 2 of 22 portal tracts. Despite a severe presentation, she achieved complete biochemical and clinical recovery within 6 months. This case expands the spectrum of drug-induced VBDS in children and highlights the potential for favorable outcomes despite significant duct loss.

Authors

Institutions

Publication Details

Journal
JPGN Reports
Published
2026-11-12
DOI
https://doi.org/10.1002/jpr3.70283
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Vanishing act: A case report of atovaquone–proguanil‐induced vanishing bile duct syndrome in a pediatric patient

Dinesh Rakheja, Alexandra E. Pottorff, Angela E. Scheuerle, Kathryn Kaihlanen et al.
JPGN Reports
Drug-Induced Hepatotoxicity and Protection
article

Vanishing act: A case report of atovaquone–proguanil‐induced vanishing bile duct syndrome in a pediatric patient

Dinesh Rakheja, Alexandra E. Pottorff, Angela E. Scheuerle, Kathryn Kaihlanen, Isabel Rojas, Aakash Goyal
article en

Abstract

Drug-induced vanishing bile duct syndrome (VBDS) is a rare complication of severe cholestatic hepatitis characterized by progressive ductopenia despite withdrawal of the offending agent. Prognosis ranges from gradual recovery to liver failure requiring transplantation. We report the first known pediatric case of biopsy-confirmed VBDS following atovaquone-proguanil exposure. An 11-year-old girl developed severe cholestatic hepatitis approximately 2 months after a 21-day course of malaria prophylaxis. Liver biopsy demonstrated marked ductopenia, with bile ducts identified in only 2 of 22 portal tracts. Despite a severe presentation, she achieved complete biochemical and clinical recovery within 6 months. This case expands the spectrum of drug-induced VBDS in children and highlights the potential for favorable outcomes despite significant duct loss.

JPGN Reports
The University of Texas Southwestern Medical Center (US)
Good health and well-being
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon